![]() |
|
|
Vol. 295, Issue 1, 16-22, October 2000
-Linked Acidic Dipeptidase
Converts N-Acetylaspartylglutamate from a
Neuroprotectant to a Neurotoxin
Guilford Pharmaceuticals Inc., Baltimore, Maryland
We previously reported that inhibition of the brain enzyme
N-acetylated
-linked acidic dipeptidase (NAALADase;
glutamate carboxypeptidase II) robustly protects cortical neurons from
ischemic injury. Since NAALADase hydrolyzes
N-acetylaspartylglutamate (NAAG) to glutamate we
hypothesized that inhibiting NAALADase would both decrease glutamate
and increase NAAG. Increasing NAAG is potentially important because
NAAG is a metabotropic glutamate receptor agonist and an
N-methyl-D-aspartate (NMDA) partial
antagonist, both of which have previously been shown to be
neuroprotective. To understand the likely effects of endogenous NAAG in
the central nervous system, we have now investigated the activity of
NAAG in primary cortical cultures while manipulating NAALADase
activity. Under hydrolyzing conditions, when NAALADase was active, NAAG
had toxic effects that were blocked by NMDA and
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate
receptor antagonists and by NAALADase inhibition. NAAG's toxic effects
were presumably due to the liberation of glutamate. Under
nonhydrolyzing conditions, when NAALADase was inhibited, NAAG
demonstrated neuroprotective effects against both NMDA toxicity and
metabolic inhibition. In the case of NMDA-induced toxicity, NAAG
provided neuroprotection through its partial antagonist activity at the
NMDA receptor. In the case of metabolic inhibition, NAAG had an
additional neuroprotective effect mediated through its agonist
properties at the type II metabotropic glutamate receptor. These
results indicate that NAAG might play an important role in the central
nervous system, under certain pathological conditions, as a neurotoxin
or as a neuroprotectant, depending on the activity of NAALADase.
This article has been cited by other articles:
![]() |
E. R. Garrido Sanabria, K. M. Wozniak, B. S. Slusher, and A. Keller GCP II (NAALADase) Inhibition Suppresses Mossy Fiber-CA3 Synaptic Neurotransmission by a Presynaptic Mechanism J Neurophysiol, January 1, 2004; 91(1): 182 - 193. [Abstract] [Full Text] |
||||
![]() |
S.-R. Chen, K. M. Wozniak, B. S. Slusher, and H.-L. Pan Effect of 2-(Phosphono-methyl)-pentanedioic Acid on Allodynia and Afferent Ectopic Discharges in a Rat Model of Neuropathic Pain J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 662 - 667. [Abstract] [Full Text] [PDF] |
||||